BusinessHemab Therapeutics Appoints Keli Walbert to Board of Directors
Hemab Therapeutics has appointed Keli Walbert to its Board of Directors. This decision adds new leadership to the company's governance, potentially influencing its strategic direction and oversight. The appointment reflects Hemab Therapeutics' ongoing efforts to strengthen its board with experienced professionals.
Investing भारत·15h ago




